OPN is a direct target of miR181 and suppresses p53-dependent transactivation and apoptosis in tumor cells, thereby regulating the sensitivity of MCF-7 cells to doxorubicin treatment (Han et al., 2019). The gene discussed is TP53; the disease is neoplasm.